Search

everythinglearnresearchcommunity

for

Search:↓

Different PCOS subgroups have similar metabolic features, but those without menstrual problems have milder issues.

Removing one ovary helped treat a woman's severe PCOS symptoms when medicine didn't work.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Glucocorticoids can cause various health issues, but some treatments may help reduce these effects.

Women with PCOS have higher risks of heart disease, type 2 diabetes, and endometrial cancer.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

CBD may improve skin and hair health, but its effective use and safety need more research.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Mutations in the androgen receptor gene cause androgen insensitivity, leading to female traits in genetically male individuals.

Male pattern baldness is linked to specific genetic variations in the androgen receptor gene.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Hair follicle size is mainly influenced by the number of cells and extracellular matrix volume, with cell number having a larger impact.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

ERG increases SOX9, promoting prostate cancer growth and invasion.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Androgens can both increase and decrease hair growth in different parts of the body.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Blocking testosterone speeds up wound healing in males.

Sebocytes play a key role in controlling androgen levels in human skin.